Clinical Trial Update: Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating paclitaxel (Taxol), carboplatin, and bevacizumab in advanced ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Gynecologic Oncology Associates | Conditions: Ovarian Neoplasms | Phase 2 | Status: COMPLETED